Effect of osmolarity on LDL binding and internalization in hepatocytes

Am J Physiol. 1997 Oct;273(4):C1409-15. doi: 10.1152/ajpcell.1997.273.4.C1409.

Abstract

The present study has been performed to elucidate a possible role of cell volume in low-density lipoprotein (LDL) binding and internalization (LDL(b+i)). As shown previously, increase of extracellular osmolarity (OSMe) and K+ depletion, both known to shrink cells, interfere with the formation of clathrin-coated pits and thus with LDL(b+i). On the other hand, alterations of cell volume have been shown to modify lysosomal pH, which is a determinant of LDL(b+i). LDL(b+i) have been estimated from heparin-releasable (binding) or heparin-insensitive (internalization) uptake of 125I-labeled LDL. OSMe was modified by alterations of extracellular concentrations of ions, glucose, urea, or raffinose. When OSMe was altered by varying NaCl concentrations, LDL(b+i) decreased (by 0.5 +/- 0.1%/mM) with increasing OSMe and LDL(b+i) increased (by 1.2 +/- 0.1%/mM) with decreasing OSMe, an effect mainly due to altered affinity; the estimated dissociation constant amounted to 20.6, 48.6, and 131.6 micro/ml at 219, 293, and 435 mosM, respectively. A 25% increase of OSMe increased cytosolic (by 0.46 +/- 0.03) and decreased lysosomal (by 0.14 +/- 0.02) pH. Conversely, a 25% decrease of OSMe decreased cytosolic (by 0.28 +/- 0.02) and increased lysosomal (by 0.17 +/- 0.02) pH. Partial replacement of extracellular Na+ with K+ had little effect on LDL(b+i), although it swelled hepatocytes and increased lysosomal and cytosolic pH. Hypertonic glucose, urea, or raffinose did not exert similar effects despite a shrinking effect of hypertonic raffinose. Monensin, which completely dissipates lysosomal acidity, virtually abolished LDL(b+i). In conclusion, the observations reveal a significant effect of ionic strength on LDL(b+i). The effect is, however, not likely to be mediated by alterations of cell volume or alterations of lysosomal pH.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular
  • Extracellular Space / physiology
  • Heparin / pharmacology
  • Humans
  • Hydrogen-Ion Concentration
  • Hypertonic Solutions
  • Hypotonic Solutions
  • Kinetics
  • Lipoproteins, LDL / metabolism*
  • Liver / metabolism*
  • Liver Neoplasms
  • Lysosomes / physiology
  • Osmolar Concentration
  • Potassium / pharmacology
  • Receptors, LDL / metabolism*
  • Tumor Cells, Cultured

Substances

  • Hypertonic Solutions
  • Hypotonic Solutions
  • Lipoproteins, LDL
  • Receptors, LDL
  • Heparin
  • Potassium